Bioaerosols Reduction

Jamie Balarashti, Study Director
Aerosol Research and Engineering Laboratories, Kansas
Full Report


To evaluate the efficacy of the Protect 900 on neutralizing bioaerosols. The device was assessed on four aerosolized biologicals: Staphylococcus epidermidis, MS2 bacteriophage, Aspergillus niger fungus, and Bacillus subtilis endospores.


A large sealed aerosol test chamber was used to replicate a potentially contaminated room environment and to contain any potential release of aerosols into the surrounding environment. The chamber was equipped with a Protect 900, filtered HEPA inlets, digital internal temperature and humidity monitor, external humidifiers (for humidity control), lighting system, multiple sampling ports, aerosol mixing fans, and an HEPA filtered exhaust system that were operated with a wireless remote control. For testing, the chamber was equipped with stainless steel probes for aerosol sampling, a port for bioaerosol dissemination into the chamber for the bacteriophages and vegetative cells, and a dry powder eductor for the fungal and bacterial spores.

Summary of Results

Test results show that the Protect 900 was extremely effective at reducing viability of bioaerosols in all conducted studies:

99.87% reduction of Staphylococcus epidermidis bacteria

99.99% reduction of MS2, a surrogate for influenza, norovirus and SARS-CoV coronavirus

99.1% reduction of Aspergillus niger mold

86.63% reduction of Bacillus subtilis bacteria spore

Protect 800/900 achieved 99.87% reduction of staphylococcus epidermidis

Protect 800/900 achieved 99.99% reduction of MS2 Bacteriophage

Contact Us

USA Headquarters
3540 Toringdon Way, Suite 200 Charlotte, NC  28277
1 866 508 1118

Ireland Headquarters
DCU Innovation Campus
Old Finglas Road
Glasnevin, Dublin D11 KXN4
+353 1 907 2750